CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale President & CEO sold 47,853 shares at $33.52 ($1,604,033)
- 4 Grant or award Chief Financial Officer acquired 80,366 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Chief Accounting Officer sold 2,163 shares at an average $40.80 ($88,249)
- 4 Open-market sale EVP & Chief Commercial Officer sold 6,000 shares at $37.96 ($227,760)
- 4 Open-market sale SVP, Chief Accounting Officer sold 970 shares at an average $37.15 ($36,032)
- 4 Open-market sale Director sold 585 shares at $46.76 ($27,355)
- 4 Open-market sale EVP & Chief Commercial Officer sold 305 shares at $48.20 ($14,701)
- 4 Grant or award Director acquired 3,860 shares (grant or award)
- 4 Returned to the company Director returned 3,300 shares (to the company)
- 4 Open-market sale Director sold 1,485 shares at $51.65 ($76,700)
- 4 Grant or award Director acquired 3,860 shares (grant or award)
- 4 Grant or award Director acquired 3,860 shares (grant or award)
- 4 Grant or award Director acquired 3,860 shares (grant or award)
- 4 Grant or award Director acquired 3,860 shares (grant or award)
- 4 Open-market sale Pinion John Richard sold 2,012 shares at $50.00 ($100,600)
- 4 Exercise or conversion SVP, Chief Accounting Officer acquired 3,000 shares (option exercise)
- 4 Open-market sale EVP and Chief Legal Officer sold 4,378 shares at $45.00 ($197,010)
Page 6 of 32 · 627 filings